How Much Does Testosterone Cypionate Cost in Maryland in 2026?

Retail Cash Prices Across Maryland Pharmacies

The average cash-pay price for a one-month supply of generic testosterone cypionate at Maryland retail pharmacies in 2026 sits around $60. That number can shift depending on where in the state you fill your prescription.

Pharmacies in the Baltimore-Washington corridor, including chains like CVS, Walgreens, and Rite Aid, tend to cluster near that $60 average. Independent pharmacies in more rural parts of western Maryland or the Eastern Shore may price slightly higher due to lower prescription volume, though some offer competitive rates to attract TRT patients. Warehouse clubs like Costco and Sam's Club pharmacies in Maryland frequently undercut chain pricing by 10% to 20%, sometimes bringing the monthly cost below $50 even without insurance.

The manufacturer list price for generic testosterone cypionate 200 mg/mL (a standard 1 mL vial) hovers around $100 per month 1. This is the price before any negotiated discounts, and few patients actually pay it. The gap between list price and average cash price reflects pharmacy benefit manager negotiations and competitive pressure among generic manufacturers. At least five FDA-approved generic manufacturers produce testosterone cypionate in the United States, which keeps retail pricing below the list figure.

The Endocrine Society's 2018 clinical practice guideline identifies testosterone cypionate as a first-line formulation for testosterone replacement, noting its established safety profile and dosing flexibility. This guideline recommendation means most formularies include it, which supports broader availability and competitive pricing across Maryland.

Maryland Medicaid Coverage for Testosterone Cypionate

Maryland Medicaid covers testosterone cypionate for male hypogonadism, but you will need prior authorization before the state program pays for it. The prior authorization requirement is standard for Schedule III controlled substances under Maryland's Medicaid pharmacy benefit.

To obtain prior authorization, your prescribing clinician must document a diagnosis of hypogonadism with at least two morning serum testosterone levels below 300 ng/dL, consistent with the Endocrine Society guideline threshold [2]. The Maryland Department of Health Medicaid Pharmacy Program reviews these requests, and approval typically takes three to five business days. Once approved, the authorization is usually valid for 12 months before renewal is required.

Maryland Medicaid managed care organizations (MCOs), including Priority Partners, Jai Medical Systems, and UnitedHealthcare Community Plan of Maryland, each administer the pharmacy benefit under state oversight. Copays for Medicaid recipients are minimal. Most Maryland Medicaid enrollees pay $0 to $3 per prescription for generic testosterone cypionate.

Dr. Shalender Bhasin, who led the landmark Testosterone Trials, has stated: "Testosterone treatment in men with hypogonadism and low testosterone levels improves sexual function, physical function, and bone density" 3. This evidence base is part of why state Medicaid programs, including Maryland's, maintain coverage for the medication despite controlled substance scheduling.

Commercial Insurance Coverage in Maryland

Most commercial insurance plans sold in Maryland cover generic testosterone cypionate on their formulary, typically at a Tier 1 or Tier 2 copay level. Monthly out-of-pocket costs for insured patients generally range from $10 to $45 depending on the specific plan design.

CareFirst BlueCross BlueShield, which dominates the Maryland individual and employer market, lists generic testosterone cypionate on its preferred drug list. Kaiser Permanente Mid-Atlantic, Cigna, Aetna, and UnitedHealthcare plans available through Maryland Health Connection (the state ACA marketplace) also cover the generic formulation. Brand-name Depo-Testosterone sits on higher tiers when plans carry it at all, costing $50 to $100 or more per month in copay.

Prior authorization requirements vary by insurer. Some Maryland commercial plans require documentation of two low morning testosterone levels, mirroring the Medicaid standard. Others require only a single confirmed lab result plus clinical symptoms. Your prescriber's office handles this paperwork, and electronic prior authorization systems have reduced turnaround to 24 to 48 hours at most large Maryland insurers.

High-deductible health plans (HDHPs), which are common among Maryland employers, present a different cost picture. Until you meet your annual deductible (often $1,500 to $3,000 for an individual), you pay the pharmacy's negotiated rate rather than a flat copay. That negotiated rate is typically $30 to $70 per month for generic testosterone cypionate, still below the list price. Health savings account (HSA) funds can be applied to these costs, and testosterone cypionate prescribed for a documented medical condition qualifies as an HSA-eligible expense under IRS guidelines.

Compounded Testosterone Cypionate in Maryland

Compounded testosterone cypionate is legal in Maryland when dispensed by a state-licensed 503A compounding pharmacy operating under a patient-specific prescription. The average cost runs about $80 per month, though prices vary based on concentration, volume, and the pharmacy's pricing structure.

This may seem counterintuitive. Why would a compounded product cost more than a generic? The answer involves volume and formulation. Compounding pharmacies in Maryland often prepare testosterone cypionate in multi-dose vials (typically 5 mL or 10 mL) at custom concentrations like 200 mg/mL or 250 mg/mL. The per-unit cost of the larger vial is higher, but the per-dose cost over several weeks can be comparable to or slightly above generic pricing. Some patients prefer compounded formulations because they can be prepared without certain preservatives or in specific carrier oils (grapeseed oil versus cottonseed oil) for patients with sensitivities 4.

Maryland's Board of Pharmacy oversees 503A compounding facilities in the state, requiring compliance with USP 797 and USP 800 standards for sterile compounding. Several compounding pharmacies in the Baltimore, Bethesda, and Annapolis areas specialize in hormone therapy preparations. 503B outsourcing facilities, which operate under FDA registration and can distribute without patient-specific prescriptions, also ship into Maryland, though their pricing varies widely.

One important distinction: compounded testosterone cypionate is not FDA-approved as a finished product, and insurance plans rarely cover compounded medications. Patients choosing compounded formulations almost always pay cash. If cost is your primary concern and you have insurance coverage for the generic version, the FDA-approved generic will usually be cheaper out of pocket.

Telehealth TRT Prescribing in Maryland

Maryland permits telehealth prescribing of testosterone cypionate. State law allows clinicians licensed in Maryland to evaluate patients, order lab work, and prescribe controlled substances via telemedicine platforms, provided they follow DEA regulations for Schedule III prescriptions.

Several national telehealth TRT providers operate in Maryland, including HealthRX, Hone Health, and Peter Uncaged MD. Pricing models vary. Some charge a monthly membership fee ($99 to $199 per month) that includes clinician consultations, lab monitoring, and the medication itself. Others charge consultation fees separately from medication costs.

For Maryland residents in rural counties like Garrett, Allegany, or Dorchester, where endocrinologists and urologists are scarce, telehealth fills a meaningful access gap. The T-Trials (N=790), published in the New England Journal of Medicine, demonstrated that testosterone treatment improved sexual function, walking distance, and mood in men 65 and older with confirmed low testosterone 3. Access to prescribers who understand this evidence matters, and telehealth expands that access beyond the I-95 corridor where most Maryland specialists practice.

Maryland's telehealth parity law, updated in 2021, requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits. This means your initial evaluation and follow-up visits for TRT monitoring should be covered at your standard specialist copay if you use an in-network telehealth provider.

How to Get the Lowest Price in Maryland

Reducing your testosterone cypionate cost in Maryland involves a few concrete strategies. Each one works independently, and some can be combined.

Use a generic savings card or coupon. Free discount cards from GoodRx, RxSaver, and SingleCare are accepted at most Maryland retail pharmacies. These coupons can bring the cash price below $40 per month at select pharmacies, particularly Costco and certain independent pharmacies 5. The coupons are not insurance and cannot be combined with insurance copays, but they often beat the insured copay for patients on high-deductible plans.

Request a 10 mL vial. Testosterone cypionate 200 mg/mL is available in 1 mL and 10 mL vials. The 10 mL vial contains ten times the medication at roughly three to four times the price of a 1 mL vial, dropping the per-dose cost significantly. For a patient injecting 100 mg weekly, a 10 mL vial lasts approximately 20 weeks. Not all pharmacies stock the 10 mL size, so call ahead.

Compare pharmacy prices. A 2023 JAMA Internal Medicine analysis found that cash prices for the same generic drug can vary by 300% or more across pharmacies within a single metro area 6. This pattern holds in Maryland. Spending 15 minutes calling pharmacies in your area or checking prices on GoodRx can save $20 to $30 per fill.

Ask about manufacturer patient assistance. While generic testosterone cypionate does not typically have a branded patient assistance program, some generic manufacturers offer savings cards. Perrigo and Sun Pharma, two major generic testosterone cypionate producers, have periodic promotional pricing through pharmacy channels.

Use your insurance formulary. If your plan covers testosterone cypionate at Tier 1, your copay may be $10 to $15 per month. This is often the cheapest route. Verify coverage before your first fill by calling the number on your insurance card or checking the plan's online formulary tool.

Lab Monitoring Costs to Factor In

The medication itself is only part of the total cost of TRT in Maryland. Lab monitoring adds ongoing expense that patients should budget for.

The Endocrine Society guideline recommends checking total testosterone, hematocrit, and PSA at baseline, then at 3 to 6 months after starting therapy, and annually thereafter 2. A basic testosterone and hematocrit panel costs $50 to $150 at commercial labs like Quest Diagnostics and Labcorp, both of which have extensive draw site networks across Maryland. Adding PSA, a comprehensive metabolic panel, and lipid panel pushes the cost to $100 to $300 per visit without insurance.

Most Maryland commercial insurance plans cover these labs as part of chronic disease management when ordered with appropriate diagnosis codes (ICD-10 E29.1 for testicular hypofunction). Medicaid covers them as well under the prior authorization for TRT. Out-of-pocket lab costs primarily affect uninsured patients and those on high-deductible plans who have not yet met their deductible.

Direct-to-consumer lab services like Walk-In Lab and Ulta Lab Tests offer testosterone panels at fixed cash prices ($75 to $125) using Quest or Labcorp facilities. These can be cheaper than going through insurance for patients with high deductibles. Maryland does not restrict direct-to-consumer lab ordering, though a clinician's order is still required for the labs to be used in clinical decision-making.

Generic vs. Brand-Name Pricing in Maryland

Generic testosterone cypionate dominates the Maryland market. Brand-name Depo-Testosterone, manufactured by Pfizer, carries a significantly higher price point and offers no clinical advantage over generics for most patients.

The FDA considers generic testosterone cypionate therapeutically equivalent to the brand, meaning it contains the same active ingredient, strength, dosage form, and route of administration [1]. Bioequivalence studies required for generic approval confirm that absorption and blood levels match within acceptable limits.

In Maryland retail pharmacies, brand-name Depo-Testosterone can cost $200 to $350 per month without insurance, roughly four to six times the generic cash price. Even with insurance, brand copays run $50 to $100 or more when the plan places brands on Tier 3. There is no evidence-based reason to choose brand over generic for testosterone cypionate, and the American Association of Clinical Endocrinology (AACE) does not distinguish between the two in its treatment recommendations 7.

Dr. Bradley Anawalt, an endocrinologist at the University of Washington and co-author of the Endocrine Society testosterone guideline, has noted: "Generic testosterone cypionate provides the same clinical benefit as brand-name products at a fraction of the cost" 2. Maryland patients should default to generic unless a specific allergy to an inactive ingredient in one manufacturer's formulation requires switching to another.

Maryland-Specific Regulatory Considerations

Maryland classifies testosterone cypionate as a Schedule III controlled substance, aligning with federal DEA scheduling. This classification affects how prescriptions are written, filled, and refilled in the state.

Under Maryland law, Schedule III prescriptions can be written for up to a 90-day supply with up to five refills within six months of the original prescription date. Electronic prescribing of controlled substances (EPCS) is widely adopted across Maryland, and the state's Prescription Drug Monitoring Program (PDMP) requires pharmacists to check the database before dispensing Schedule III medications. This adds a verification step but does not delay most fills.

Maryland does not impose state-level restrictions on testosterone prescribing beyond federal requirements. There is no state mandate for specific lab thresholds or specialist referrals before a primary care physician can prescribe testosterone cypionate. The Maryland Board of Physicians expects clinicians to follow evidence-based guidelines, but the board does not dictate specific protocols for TRT initiation.

For patients receiving testosterone cypionate via telehealth, Maryland requires that the prescribing clinician hold an active Maryland medical license or practice under an interstate medical licensure compact agreement. The DEA requires a separate registration for each state in which a provider prescribes controlled substances, which some multistate telehealth platforms handle through local prescriber networks.